Serum micro-RNA Identifies Early Stage Colorectal Cancer in a Multi-Ethnic Population.

Area of Science:

• Biochemistry
• Oncology
• Molecular Biology

Background:

• MicroRNAs (miRs) are implicated in various cancers and detectable in blood.
• Previous studies on miRs for colorectal cancer (CRC) screening were limited to homogeneous ethnic groups.
• The diagnostic performance of miRs in multiethnic populations remains largely unknown.

Purpose of the Study:

• To evaluate the efficacy of specific microRNAs (miRs) for early-stage colorectal cancer (CRC) detection.
• To assess the utility of miRs in a multiethnic patient cohort.
• To determine if selected miRs can serve as biomarkers for CRC screening.

Main Methods:

• Four microRNAs (miRs) with known aberrant expression in CRC were selected.
• The study involved a multiethnic population comprising 73 CRC cases and 18 controls.
• The ability of miRs to differentiate early-stage CRC was assessed using blood samples.

Main Results:

• Ratios of non-vesicular to extracellular vesicular levels of miR-21, miR-29a, and miR-92a correlated with CRC stage.
• These miR ratios demonstrated statistical and quantitative significance when compared to controls.
• The selected miRs showed potential as biomarkers for CRC staging.

Conclusions:

• Serum levels of miR-21, miR-29a, and miR-92a significantly detected early-stage CRC.
• These findings highlight the potential of miRs for colorectal cancer screening in multiethnic populations.
• Further validation in larger, diverse cohorts is warranted to confirm diagnostic utility.